Dr. Martens (DRMTY)
Dr. Martens Statistics
Share Statistics
Dr. Martens has 482M shares outstanding. The number of shares has increased by 0.38% in one year.
| Shares Outstanding | 482M |
| Shares Change (YoY) | 0.38% |
| Shares Change (QoQ) | 0.23% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 388.65M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 12.06 and the forward PE ratio is null. Dr. Martens's PEG ratio is -0.26.
| PE Ratio | 12.06 |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| Forward PS | n/a |
| PB Ratio | 2.27 |
| P/FCF Ratio | 5.98 |
| PEG Ratio | -0.26 |
Enterprise Valuation
Dr. Martens has an Enterprise Value (EV) of 2.03B.
| EV / Sales | 2.31 |
| EV / EBITDA | 10.33 |
| EV / EBIT | 12.07 |
| EV / FCF | 14.53 |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 1.27.
| Current Ratio | 2.85 |
| Quick Ratio | 1.19 |
| Debt / Equity | 1.27 |
| Debt / EBITDA | 2.39 |
| Debt / FCF | 3.36 |
| Interest Coverage | 6.37 |
Financial Efficiency
Return on Equity is 18.79% and Return on Invested Capital is 17.2%.
| Return on Equity | 18.79% |
| Return on Assets | 7.27% |
| Return on Invested Capital | 17.2% |
| Revenue Per Employee | $333.5K |
| Profits Per Employee | $26.31K |
| Employee Count | 2,630 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 1.19 |
Taxes
| Income Tax | 23.8M |
| Effective Tax Rate | 25.59% |
Stock Price Statistics
The stock price has increased by -45.5% in the last 52 weeks. The beta is 0.07, so Dr. Martens's price volatility has been higher than the market average.
| Beta | 0.07 |
| 52-Week Price Change | -45.5% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 26.07 |
| Average Volume (20 Days) | 114 |
Income Statement
In the last 12 months, Dr. Martens had revenue of 877.1M and earned 69.2M in profits. Earnings per share was 0.14.
| Revenue | 877.1M |
| Gross Profit | 575.2M |
| Operating Income | 197.5M |
| Net Income | 69.2M |
| EBITDA | 196.3M |
| EBIT | 124M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 111.1M in cash and 468.6M in debt, giving a net cash position of -357.5M.
| Cash & Cash Equivalents | 111.1M |
| Total Debt | 468.6M |
| Net Cash | -357.5M |
| Retained Earnings | 1.75B |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was 167.9M and capital expenditures -28.4M, giving a free cash flow of 139.5M.
| Operating Cash Flow | 167.9M |
| Capital Expenditures | -28.4M |
| Free Cash Flow | 139.5M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 65.58%, with operating and profit margins of 22.52% and 7.89%.
| Gross Margin | 65.58% |
| Operating Margin | 22.52% |
| Pretax Margin | 10.6% |
| Profit Margin | 7.89% |
| EBITDA Margin | 22.38% |
| EBIT Margin | 22.52% |
| FCF Margin | 15.9% |
Dividends & Yields
DRMTY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 8.29% |
| FCF Yield | 8.36% |
Analyst Forecast
Currently there are no analyst rating for DRMTY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |